We are living in an advanced world, which has changed its life style completely, and with change in life style many new complications have taken birth. Obesity is a disease, which has its lineage with modern life style. We are sustaining our lives in a hectic schedule where we don't have time to pay proper attention to our body. Even when people caught in diseases like cold, fever etc. they hardly get time to take an appointment with the doctor. Obesity and problems related with it do not affect rapidly. They appear slowly and consequently till then people are ignorant about increasing size of their tummy.

One more habit which modern life style brings with it is dependence on junk food. Two minutes cooking or ready to eat eatables don't have nutrients in a balanced amount. These foods are rich in fats and carbohydrates but deficient in vitamins, minerals and proteins. These foods give us excessive calories, which are accumulated in the body in the form of fat. This accumulation of fat beneath the skin provides us a bulky appearance.

Nature has provided us the capability of burning this accumulation of fat through proper physical work. An obese whenever burns fat through exercising; it is regained from excessive intake of calories. Therefore, it is essential for anyone who wants to loose weight to have control over his or her dietary habits. People generally find it difficult to have a control over their dietary habits because of adjustment of body to excessive amount of food intake.

For all such obese who are desperate to loose weight but find it difficult to have control over appetite, Acomplia (Rimonabant) can be a great help. Sanofi-Aventis of France recently launched this high efficacy diet suppressor in the European anti-obesity drug market. The sale of Acomplia firstly started in the UK where numerous obese have reduced weight successfully with its help. Sanofi-Aventis is planning to start the sale of this medication in other countries of Europe like Germany, Norway, Iceland etc. There are about 25 European countries where this medication can be sold. Sanofi-Aventis has got license in this regard by an agreement signed by 25 members of European Union. Sanofi-Aventis is planning to launch this drug in the US for which FDA approval is anticipated very soon.

Acomplia contains Rimonabant as its active ingredient, which blocks functioning of CB-1 receptors. Blocked CB-1 receptors cannot send signals of hunger to the brain, which suppress appetite with high efficacy and the person using Acomplia may not feel the urge for food. This way, the supply line of excessive calories to the body is cut. The use of Acomplia makes the process of loosing weight quick; even with moderate exercising a number of pounds can be deducted from the body. Acomplia is an oral prescription drug whose dosages are generally of 20mg in volume and swallowed daily with a glass of plain water before breakfast.

There may be some mild side effects related with Acomplia like dizziness, nausea, constipation and stomach disorder, which generally disappear with regular use of this drug for a few days. This high efficacy drug Acomplia Rimonabant is easily available through an online order; online doctor's prescription for Acomplia is also available. The delivery of online purchase of Acomplia is made at your doorstep.